Lead author Professor Ledermann, professor of medical oncology at the UCL Cancer Institute and a Cancer Research UK grantee, said: «A well - tolerated anti-tumour agent that could be used for months or perhaps years as maintenance therapy
after standard chemotherapy could be a big step forward and ultimately extend survival.
Not exact matches
«I hope that someday all of you on the advisory committee can tell your families for generations that you were part of the process that ended the use of toxic treatments like
chemotherapy and radiation as
standard treatment, and turned blood cancers into a treatable disease that even
after relapse most people survive.»
The targeted radiotherapy shrank tumors for 71 % of patients who had already failed
standard chemotherapy, but these results came from a small trial that started with 30 patients and then added another 20
after positive data started rolling in.
After 12 months, 36 percent of the nivolumab group was alive, compared to just 17 percent of the
standard chemotherapy group.
For patients with cervical cancer that has recurred
after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to
standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression - free survival, researchers report at the ESMO 2014 Congress in Madrid.
Voice - Box Saved with New Larynx Cancer Therapy
Standard therapy changes for larynx cancer, and, the voice box is spared,
after Kimmel Cancer Center investigators prove that, for most patients, combined treatment with
chemotherapy and radiation has the same success rate as surgically removing the cancerous voice box.
New
Standard of Care A 50 - year - old method for delivering
chemotherapy directly into the abdomen was reevaluated for patients with ovarian cancer
after a seven - year study of more than 400 patients revealed increased survival rates in patients with advanced ovarian cancer.
The first study found that adding Avastin to
standard chemotherapy (carboplatin and paclitaxel) and continuing with «maintenance» Avastin
after chemo actually slowed the time - to - disease recurrence in women with advanced ovarian cancer.